Data Sheet
Understanding The 505(b)(2) Approval Pathway
Discover how Camargo Pharmaceutical Services’ expertise in the 505(b)(2) approval pathway can teach old dogs new tricks. In this Q&A, Ken Phelps discusses 505(b)(2) - how it differs from 505(b)(1), its myriad of benefits, its continuing evolution, and its current and future impact on drug development.